FDA Clearance Tracker · P100029-S003
TRIFECTA HEART VALVE
Last checked: Nov 20, 2026Latest source record: Dec 22, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Dec 22, 2011
Approved
Time to decision
216 days
Received May 20, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100029-S003
- Device name
- TRIFECTA HEART VALVE
- Applicant
- ABBOTT MEDICAL
- Applicant location
- St. Paul, MN
- Received
- May 20, 2011
- Decided
- Dec 22, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P100029
Device type
- Device type
- heart-valve, non-allograft tissue (LWR)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR AN ADDITIONAL STERILIZATION SITE AND FOR FINAL PACKAGING OPERATIONS LOCATED AT ST. JUDE MEDICAL, PAMPULHA, BRAZIL.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.